Scopolamine Patch, Extended Release
Product Images NDC 69238-1662

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 69238-1662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Scopolamine Transdermal System 1)

FDA Label Image

Patch System (Scopolamine Transdermal System 2)

FDA Label Image

Figure 1 (Scopolamine Transdermal System 3)

This is a description of Figure 1 showing a transparent, dimpled, and oversized release liner with a white to off-white adhesive surface. The tan backing membrane is printed with "*Scopolamine 1 mg/3 days™".*

FDA Label Image

Figure 2 (Scopolamine Transdermal System 4)

This text provides instructions to "cut package open along dashed line" which indicates where to open the packaging for the item. It likely accompanies a visual representation in Figure 2 for guidance.*

FDA Label Image

Figure 3 (Scopolamine Transdermal System 5)

FDA Label Image

Figure 4 (Scopolamine Transdermal System 6)

This text appears to describe a transdermal system with a tan printed design and a white to off-white adhesive surface. The system also features a transparent, dimpled, and oversized release liner.*

FDA Label Image

Figure 5 (Scopolamine Transdermal System 7)

FDA Label Image

Pouch (Scopolamine Transdermal System 8)

This text contains information about a Scopolamine Transdermal System with a concentration of 1 mg/3 days. It provides cautions about washing hands immediately after application and potential eye irritation. The system should not be cut, and only one should be used at a time. Other instructions on usage, dosage, administration, and storage are also given. The product may cause drowsiness, blurred vision, and should be kept out of reach of children. Finally, it mentions the distributor as Amneal Pharmaceuticals LLC from Bridgewater, NJ.*

FDA Label Image

Carton (Scopolamine Transdermal System 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.